Hypertension in pregnancy: The management of hypertensive disorders during pregnancy

NICE guidelines [CG107] Published date:

Review decision: 

This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.

Register as a stakeholder

Next review date: March 2015

This clinical guideline offers evidence-based advice on the care and treatment of women who have or are at risk of developing hypertension (high blood pressure) in pregnancy. It contains advice on the diagnosis and management of hypertension during pregnancy, birth and the postnatal period. It also includes advice for women with chronic hypertension who wish to conceive and for women who have had a pregnancy complicated by hypertension.

  • January 2011

    Two corrections have been made to the full version of this guideline as well as to the NICE version and the Quick Reference Guide.

    In the section Management of pregnancy with chronic hypertension 'and' has been changed to 'or' in the following recommendation (recommendation in the NICE version). It now reads:

    Tell women who take angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs):

    • that there is an increased risk of congenital abnormalities if these drugs are taken during pregnancy
    • to discuss other antihypertensive treatment with the healthcare professional responsible for managing their hypertension, if they are planning pregnancy.

    In addition, 'chlorothiazide diuretics' has been changed to 'chlorothiazide' in recommendations and in the NICE guideline and throughout the full guideline. These changes have been made on pages 4 and 8 of the Quick Reference Guide. Implementation tools have also been updated.

  • Get involved